Anti-fibrillarin antibodies are said to be associated with male patients, younger age of onset compared to other SSc patients, phalangeal ulcers, skeletal muscle lesions, diffuse sclerosing skin lesions, severe small bowel lesions, and PH [4,12-14,16]. The gene discussed is FBL; the disease is systemic sclerosis.